Genealogy, expression, and cellular function of transforming growth factor-β

Pharmacology and Therapeutics

Volumn 98, Issue 2, 2003, Pages 257-265

  Govinden, R ^a   Bhoola, K D ^b  

^a SOUTH AFRICAN MEDICAL RESEARCH COUNCIL   (South Africa)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Cancer; Inflammation; Repair; Signalling; Transforming growth factor

Indexed keywords

ISOPROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANGIOGENESIS; CARCINOGENESIS; CELL FUNCTION; DRUG EFFECT; GENE EXPRESSION; HUMAN; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR; TRANSCRIPTION REGULATION;

EID: 0037407769     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(03)00035-4     Document Type: Review

References (101)

1. Adler H.L., McCurdy M.A., Kattan M.W., Time T.L., Scardino P.T., Thompson T.C. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma. J. Urol. 161:1999;182-187.
2. Alexandrow M.G., Moses H.L. Transforming growth factor β1 inhibits mouse keratinocytes late in G1 independent of effects on gene transcription. Cancer Res. 55:1995;1452-1457.
3. Assoian R.K., Komoriya A., Meyers C.A., Miller D.M., Sporn M.B. Transforming growth factor-β in human platelets. Identification of a major storage site, purification and characterisation. J. Biol. Chem. 258:1983;7155-7160.
4. Assoian R.K., Grotendorst G.R., Miller D.M., Speared M.B. Cellular transformation by coordinated action of three peptide growth factors from human platelets. Nature. 309:1984;804-806.
5. Attisano L., Wrana J.L. Signal transduction by members of the transforming growth factor β superfamily. Cytokine Growth Factor Rev. 7:1996;327-339.
6. Attisano L., Wrana J.L. Smads as transcriptional co-modulators. Curr. Opin. Cell Biol. 12:2000;235-243.
7. Attisano L., Crcamo J., Ventura F., Weis F.M.B., Massague J., Wrana J.L. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell. 75:1993;671-680.
8. Attisano L., Wrana J.L., Lopez-Casilas F., Massague J. TGF-beta receptors and actions. Biochim. Biophys. Acta. 1222:1994;71-80.
9. Bakin A.V., Tomlinson A.K., Bhowmick N.A., Moses H.L., Artega C.L. Phosphatidylinositol 3-kinase function is required for transforming growth factor β-mediated epithelial to mesenchymal transition and cell migration. J. Biol. Chem. 275:2000;36803-36810.
10. Barrack E.R. TGF β I prostate cancer: a growth inhibitor that can enhance tumorigenicity. Prostate. 31:1997;61-70.
11. Birchenall-Roberts M.C., Ruscetti F.W., Kasper J., Lee H.D., Friedman R., Geiser A., Sporn M.B., Roberts A.B., Kim S.J. Transcriptional regulation of the transforming growth factor beta 1 promoter by v-src gene products is mediated through the AP-1 complex. Mol. Cell Biol. 10:1990;4978-4983.
12. Birchmeier W., Behrens J. Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness. Biochim. Biophys. Acta. 1198:1994;11-26.
13. Blobe G.C., Liu X., Fang S.J., How T., Lodish H.F. A novel mechanism for regulating transforming growth factor β (TGF-β) signalling. Functional modulation of type III TGF-β receptor expression through interaction with the PDZ domain protein GIPC. J. Biol. Chem. 276:2001;39608-39617.
14. Chen X., Rubock M.J., Derynck R. A transcriptional partner for Mad proteins in TGF-beta signalling. Nature (London). 383:1996;691-696.
15. 1. Kidney Int. 44:1993;948-958.
16. Clark E.A., Golub T.R., Lander E.S., Hynes R.O. Genomic analysis of metastasis reveals an essential role for RhoC. Nature (London). 406:2000;532-535.
17. Cowin A.J., Hatzirodos N., Holding C.A., Dunaiski V., Harries H., Rayner T.E., Fitridge R., Cooter R.D., Schultz G.S., Belford D.A. Effect of healing on the expression of transforming growth factor beta(s) and their receptors in chromic venous leg ulcers. J. Physiol. 96:2002;25-30.
18. Cui W., Fowlis D.J., Brysons S., Duffie E., Ireland H., Balmain A., Akhurstm R.J. TGFβ1 inhibits the formation of benign skin tumors, but enhances the progression to invasive spindle carcinomas in transgenic mice. Cell. 86:1996;531-542.
19. Dennler S., Itoh S., Vivien D., ten Dijke P., Huet S., Gauthier J. Direct binding of Smad3 and Smad4 to critical TGF β-inducible elements in the promoter of human plasminogen activator inhibitor-type 1 gene. EMBO J. 17:1998;3091-3100.
20. Dennler S., Prunier C., Ferrand N., Gauthier J.M., Atfi A. c-Jun inhibits transforming growth factor β-mediated transcription by repressing Smad3 transcriptional activity. J. Biol. Chem. 275:2000;28858-28865.
21. Derynck R., Jarrett J.A., Che E.Y., Eaton D.H., Bell J.R., Assoian R.K., Roberts A.B., Speared M.B., Goeddel D.V. Human transforming growth factor-b cDNA sequence and expression in tumor cell lines. Nature (London). 316:1985;701-705.
22. Derynck R., Zhang Y., Feng X.H. Smads: transcriptional activators of TGF-β responses. Cell. 95:1998;737-740.
23. Dey B.R., Sukhatme V.P., Roberts A.B., Sporn M.B., Rauscher F.J., Kim S.J. Repression of the transforming growth factor-β1 gene by the Wilm's tumour suppressor WT1 gene product. Mol. Endocrinol. 8:1994;595-602.
24. Doré J.J.E., Yao D., Edens M., Garamszegi N., Sholl E.L., Leof E.B. Mechanisms of transforming growth factor-β receptor endocytosis and intracellular sorting differ between fibroblasts and epithelial cells. Mol. Biol. Cell. 12:2001;675-684.
25. Franzen P., ten Dijke P., Ichijo H., Yamashita H., Schulz P., Heldin C.H., Miyazono K. Cloning of a TGF β type I receptor that forms a heteromeric complex with the TGF β type II receptor. Cell. 75:1993;681-692.
26. Frolik C.A., Dart L.L., Meyers C.A., Smith D.M., Sporn M.B. Purification and initial characterisation of a type beta transforming growth factor from human placenta. Proc. Natl. Acad. Sci. USA. 80:1983;3676-3680.
27. Gajdusek C.M., Luo Z., Mayberg M.R. Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro. J. Cell Physiol. 157:1993;133-144.
28. Garamszegi N., Dore J.J.E., Penheiter S.G., Edens M., Yao D., Leof E.B. Transforming growth factor β receptor signalling and endocytosis are linked through a COOH terminal activation motif in the type I receptor. Mol. Biol. Cell. 12:2001;2881-2893.
29. Gleizes P.E., Beavis R., Mazzieri R., Shen B., Rifkin D.B. Identification and characterisation of an eight-cysteine repeat of the latent transforming growth factor-β binding protein-1 that mediates bonding to the latent transforming growth factor-β J. Biol. Chem. 271:1996;29891-29896.
30. Gobbi H., Arteaga C.L., Jensen R.A., Simpson J.F., DuPont W.D., Olson S.J., Schuyler P.A., Plummer W.D.J., Page D.L. Loss of expression of transforming growth factor-beta type II receptor correlates with high tumour grade in human breast in situ and invasive carcinomas. Histopathology. 36:2000;168-177.
31. Grady W.M., Rajput A., Myeroff L., Liu D.F., Kwon K., Willis J., Markowitz S. Mutation of the type II transforming growth factor beta receptor is coincident with the transformation of human colon adenomas to malignant carcinomas. Cancer Res. 58:1998;3101-3104.
32. Gualandris A., Annes J.P., Arese M., Noguera I., Jurukovski V., Rifkin D.B. The latent transforming growth factor β-binding protein-1 promotes in vitro differentiation of embryonic stem cells into endothelium. Mol. Biol. Cell. 11:2000;4295-4308.
33. Guttmacher A., Marchuk D.A., White R.I. Hereditary haemorrhagic telangiectasia. N. Engl. J. Med. 333:1995;918-924.
34. Hahm K.B., Im Y.H., Parks T.W., Park S.H., Markowitz S., Jung H.Y., Green J., Kim S.L. Loss of transforming growth factor beta signalling in the intestine contributes to tissue injury in inflammatory bowel disease. Gut. 49:2001;164-165.
35. Hannon G.J., Beach D. 15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature (London). 371:1994;257-261.
36. Hata A., Lo R.S., Wotton D., Lagna G., Massague J. Mutations increasing autoinhibition inactivate tumour suppressers Smad2 and Smad4. Nature (London). 388:1997;82-87.
37. Hata A., Shi Y., Massague J. TGF-β signalling and cancer: structural and functional consequences of mutations in smads. Mol. Med. Today. 4:1998;257-262.
38. Heldin C.H., Miyazono K., ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature (London). 390:1997;465-471.
39. Hocevar B.A., Brown T.L., Howe H. TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent Smad4-independent pathway. EMBO J. 18:1999;1345-1356.
40. Hoodless P.A., Wrana J.L. Mechanism and function of signalling by the TGF beta superfamily. Curr. Top Microbiol. Immunol. 228:1998;235-272.
41. Howat W.J., Holgate S.T., Lackie P.M. TGF-β isoform release and activation during in vitro bronchial epithelial wound repair. Am. J. Physiol. Lung Cell Mol. Physiol. 282:2002;L115-L123.
42. WAF1/CIP1 by transforming growth factor-β J. Biol. Chem. 274:1999;35381-35387.
43. Ivenovic V., Melman A., Davis-Joseph B., Valcic M., Geliebter J. Elevated plasma levels or TGF-beta 1 in patients with invasive prostate cancer. Nat. Med. 1:1995;282-284.
44. Johnson D.W., Berg J.N., Baldwin M.A., Gallione C.J., Maronde I., Yoon S.J., Stenzel T.T., Speer M., Pericak-Vnce M.A., Diamond A. Mutations in the activin receptor-like kinase 1 gene in hereditary haemorrhagic telangiectasia type 2. Nat. Genet. 13:1996;189-195.
45. Kang H.Y., Lin H.K., Hu Y.C., Yeh S., Huang K., Chang C. From transforming growth factor-β signalling to androgen action: identification of Smad3 as an androgen receptor co-regulation in prostate cancer cells. Proc. Natl. Acad. Sci. USA. 98:2001;3018-3023.
46. Kim S.J., Angel P., Lafyatis R., Hattori K., Kim K.Y., Sporn M.B., Karin M., Roberts A.B. Autoinduction of transforming growth factor beta is mediated by the AP-1 complex. Mol. Cell Biol. 10:1990;1492-1497.
47. Kingsley D.M. The TGF-beta superfamily: new members, new receptors, and new genetic tests of function in different organisms. Genes Dev. 8:1994;133-146.
48. Koyama M., Ito M., Nagai H., Emi M., Moriyama Y. Inactivation of both alleles of the DPC4/SMAD4 gene in advanced colorectal cancers: identification of seven novel somatic mutations in tumors from Japanese patients. Mutat. Res. 406:1999;71-77.
49. Lafyatis R., Lechleider R., Kim S.J., Jakowlew S., Roberts A.B., Sporn M.B. Structural and functional characterization of the transforming factor β 3 promoter: a cAMP responsive element regulates basal and induced transcription. J. Biol. Chem. 265:1990;19128-19136.
50. Lee K.H., Song S.U., Hwang T.S., Yi Y., Oh I.S., Lee J.Y., Choi K.B., Choi M.S., Kim S.J. Regeneration of hyaline cartilage by cell-mediated gene therapy using transforming growth factor β1-producing fibroblasts. Hum. Gene. Ther. 12:2001;1805-1813.
51. Letterio J.J., Roberts A.B. Regulation of immuno responses by TGF. Annu. Rev. Immunol. 16:1998;137-161.
52. Liberati N.T., Datto M.B., Frederick J.P., Shen X., Wong C., Rougier-Chapman E.M., Wang X.F. Mads bind directly to the Jun family of AP-1 transcription factors. Proc. Natl. Acad. Sci. USA. 96:1999;4844-4849.
53. Liu F., Ventura F., Doody J., Massague J. Human type II receptor for bone morphogenetic proteins (BMPs): extension of the two-kinase receptor model to the BMPs. J. Mol. Cell Biol. 15:1995;3479-3486.
54. Luo K., Lodish H.F. Positive and negative regulation of type II TGF-β receptor signal transduction by phosphorylation on multiple serine residues. EMBO J. 16:1997;1970-1981.
55. Maitra A., Molberg K., Albores-Saavedra J., Lindberg G. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am. J. Pathol. 157:2000;1105-1111.
56. Massague J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6:1990;597-641.
57. Massague J. TGF-β signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
58. Massague J., Chen Y.G. Controlling TGF-β signalling. Genes Dev. 14:2000;627-644.
59. Massague J., Weis-Garcia F. Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. Pawson T., Parker P. Cancer Surveys Cell Signalling. 1996;41-64 ICRF Press, London.
60. Mazars A., Tournigand C., Mollat P., Prunir C., Ferrand N., Bourgeade M.F., Gespach C., Atfi A. Differential roles of JNK and Smad2 signaling pathways in the inhibition of c-Myc-induced cell death by TGF-β Oncogene. 19:2000;1277-1287.
61. McKaig B.C., Hughes K., Tighe P.J., Mahida Y.R. Differential expression of TGF-β isoforms by normal and inflammatory bowel disease intestinal myofibroblasts. Am. J. Physiol. Cell Physiol. 282:2002;172-182.
62. Miyazono K., ten Dijke P., Ichijo H., Heldin C.-H. Receptors for transforming growth factor β Adv. Immunol. 55:1994;181-220.
63. Munger J.S., Harpl J.G., Gleizes P.E., Mazzieri R., Nunes I., Rifkinm D.B. Latent transforming factor β: structural features and mechanisms of activation. Kidney Int. 51:1997;1376-1382.
64. Nohno T., Ishikawa T., Saito T., Hosokawa K., Noji S., Wolsing D.H., Rosenbaum J.S. Identification of a human type II receptor for bone morphogenetic protein-4 that forms differential heteromeric complexes with bone morphogenetic protein type I receptors. J. Biol. Chem. 270:1995;22522-22526.
65. Nunes I., Gleizes P.E., Metz C.N., Rifkin D.B. Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent cross-linking of latent transforming growth factor-β J. Cell Biol. 136:1997;1151-1163.
66. Oft M., Peli J., Rudaz C., Schwarz H., Beug H., Reichmann E. TGFβ is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8:1998;1243-1252.
67. Oh S.P., Seki T., Goss K.A., Imamura T., Yi Y., Donahue P., Li L., Miyazono K., ten Dijke P., Kim S., Li E. Activin receptor-like kinase 1 modulates transforming growth factor-β1 signalling in the regulation of angiogenesis. Proc. Natl. Acad. Sci. USA. 97:2000;2626-2631.
68. O'Reilly M.A., Geiser A.G., Kim S.J., Bruggeman L.A., Luu A.X., Roberts A.B., Sporn M.B. Identification of an activating transcription factor (ATF) binding site in the human transforming growth factor β 2 promoter. J. Biol. Chem. 267:1992;19938-19943.
69. Panchenko M.P., Williams M.C., Brody J.S., Yu Q. Type I receptor serine-threonine kinase preferentially expressed in pulmonary blood vessels. Am. J. Physiol. 270:1996;558-574.
70. Pepper M.S. Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity. Cytokine Growth Factor Rev. 8:1997;21-43.
71. Pepper M.S., Vassalli J.D., Orci L., Montesano R. Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis. Exp. Cell Res. 204:1993;356-363.
72. Perou C.M., Sorlie T., Eisen M.B., van de Rijn M., Jeffrey S.S., Rees C.A., Pollack J.R., Ross D.T., Johnsen H., Akslen L.A. Molecular portraits of human breast tumours. Nature (London). 406:2000;747-752.
73. Pessah M., Prunier C., Marais J., Ferrand N., Mazars A., Lallemand F., Gauthier J.M., Atfi A. c-Jun interacts with the corepressor TG-interacting factor (TGIF) to suppress Smad2 transcriptional activity. Proc. Natl. Acad. Sci. USA. 98:1996;6198-6203.
74. Piek E., Moustakas A., Kurisaki A., Heldin C.H., Ireland H., Akurs R.J., Balmain A. TGF-β type I receptor/ALK5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NmuMG breast epithelial cells. J. Cell Sci. 112:1999;4557-4568.
75. Portella G., Cuming S.A., Liddell J., Cut W., Ireland H., Akhurs R.J., Balmain A. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: implications for tumour invasion. Cell Growth Differ. 9:1998;393-404.
76. Reiss M. Transforming growth factors-β and cancer: a love-hate relationship? Oncol. Res. 9:1997;447-457.
77. Risau W. Mechanisms of angiogenesis. Nature (London). 386:1997;671-674.
78. Roberts A.B. Molecular and cell biology of TGF-β Miner. Electrolyte Metab. 24:1998;111-119.
79. Roberts A.B., Speared M.B. The transforming growth factors β Speared M.B., Roberts A.B. Handbook of Experimental Pharmacology. Peptide Growth Factors and Their Receptors. 1990;419-472 Springer, Berlin.
80. Roberts A.B., Sporn M.B. Regulation of endothelial cell growth, architecture, and matrix synthesis by TGF-beta. Am. Rev. Respir. Dis. 140:1989;1126-1128.
81. Roelen B.A.J., Rooijen M.A.V., Mummery C.L. Expression of ALK-1, a type 1 serine/threonine kinase receptor, coincides with sites of vasculogenesis and angiogenesis in early mouse development. Dev. Dyn. 9:1997;418-430.
82. Rosenweig B.L., Imamura T., Okadome T., Cox G.N., Yamashita H., ten Dijke P., Heldin C.H., Miyazono K. Cloning and characterisation of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. USA. 92:1995;7632-7636.
83. Ryden M., Imamura T., Jornval H., Belluardo N., Nevue I., Trupp M., Okadome T., ten Dijke P., Ibanez C.F. A novel type I receptor serine-threonine kinase predominantly expressed in the adult central nervous system. J. Biol. Chem. 271:1996;30603-30609.
84. Saharinen J., Keski-Oja J. Specific sequence motif of 8-Cys repeats of TGF-β binding proteins, LTBPs, creates a hydrophobic interaction surface for binding of small latent TGF-β Mol. Biol. Cell. 11:2000;2691-2704.
85. Sankar S., Mahooti-Brooks N., Bense L., MsCarthy T.L., Centrella M., Madri J.A. Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J. Clin. Invest. 97:1996;1436-1446.
86. 1 in transformed keratinocytes. Biochem. Biophys. Res. Commun. 273:2000;521-527.
87. Sun Y., Liu X., Eaton E.N., Lodish H.F., Weinberg R.A. SnoN and Ski protooncogenes are rapidly degraded in response to transforming growth factor β signalling. Proc. Natl. Acad. Sci. USA. 96:1999;12442-12447.
88. Thiagalingam S., Lengauer C., Leach F.S., Schutte M., Hahn S.A., Overhauser J., Willson J.K., Markowitz S., Hamilton S.R., Kern S.E. Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat. Genet. 13:1996;343-346.
89. Thompson T.C., Truong L.D., Timme T.L., Kadmon D., McCune B.K., Flanders K.C., Scardino P.T., Park S.H. Transforming growth factor beta-1 as a biomarker for prostate cancer. Cancer. 71:1993;1165-1171.
90. Tsukazaki T., Chang T.A., Davison A.F., Attisano L., Wrana J.L. SARA, a FYVE domain protein that recruits Smad2 to the TGFβ receptor. Cell. 95:1998;779-791.
91. Verrecchia F., Tacheau C., Schorpp-Kistner M., Angel P., Mauviel A. Induction of the AP-1 members c-Jun and JunB by TGF-β/Smad suppresses early Smad-driven gene activation. Oncogene. 20:2001;2205-2211.
92. Verrecchia F., Vindevoghel L., Lechleider R.J., Uitto J., Roberts A.B., Mauviel A. Smad3/AP-1 interactions control transcriptional responses to TGF-β in a promoter-specific manner. Oncogene. 20:2001;3332-3340.
93. 1 arrest pathway. Mol. Cell Biol. 19:1999;5913-5922.
94. Wrana J.L. TGFβ receptors and signalling mechanisms. Miner. Electrolyte Metab. 24:1998;120-130.
95. Wrana J.L., Attisano L., Wieser R., Ventua F., Massague J. Mechanism of activation of TGF-beta receptor. Nature (London). 370:1994;341-347.
96. Xu J., Attisano L. Mutations in the tumour suppressors Smad2 and Smad4 inactivate transforming growth factor β signalling by targeting Smads to the ubiquitin-proteasome pathway. Proc. Natl. Acad. Sci. USA. 97:2000;4820-4825.
97. Xu G., Chakraborty C., Lala P.K. Expression of TGF-β signalling genes in the normal, premalignant, and malignant human trophoblast: loss of smad3 in choriocarcinoma cells. Biochem. Biophys Res Commun. 287:2001;47-55.
98. Yin J.J., Selander K., Chirgwin J.M., Dallas M., Grubbs B.G., Wieser R., Massage J., Mundy B.R., Guise T.A. TGF-β signaling blockage inhibits PTHrP secretion by breast cancer cells and bone metastases development. J. Clin. Invest. 103:1999;197-206.
99. Yue J., Mulder K.M. Transforming growth factor-β signal transduction in epithelial cells. Biol. Chem. 75:2000;30765-30773.
100. Zavadil J., Bitzer M., Liang D., Yang Y., Masami A., Knees S., Peek E., Bottinger P. Genetic programmes of epithelial cell plasticity directed by transforming growth factor-β Proc. Natl. Acad. Sci. USA. 98:2001;6686-6691.
101. Zhang Y., Feng X.H., Derynck R. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature (London). 394:1998;909-913.